PALVELLA THERAPEUTICS, INC.

PVLA · Nasdaq · SIC 2834: Pharmaceutical Preparations
305
SEC Filings

Business Summary

3 Item 1A. Risk Factors 49 Item 1B. Unresolved Staff Comments 104 Item 1C. Cybersecurity 104 Item 2. Properties 104 Item 3. Legal Proceedings 105 Item 4. Mine Safety Disclosures 105 PART II Item 5. Market for Registrants Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 106 Item 6. [Reserved] 106 Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations 107 Item 7A. Quantitative and Qualitative Disclosures About Market Risk 12...

Next Earnings

Q2 FY2026 — expected 2026-09-13

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionPVLAdiscussed_in_filing Cybersecurity
topic_mentionPVLAdiscussed_in_filing Cybersecurity
topic_mentionPVLAdiscussed_in_filing Cybersecurity
topic_mentionPVLAdiscussed_in_filing Cybersecurity

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-312025-12-310001193125-26-133372EDGAR104K words
2025-03-312024-12-310000950170-25-047212EDGAR—
2024-03-292023-12-310001437749-24-010123EDGAR—
2023-03-312022-12-310001437749-23-008834EDGAR—
2022-03-022021-12-310001583648-22-000016EDGAR—
2021-03-312020-12-310001583648-21-000005EDGAR—
2020-03-132019-12-310001583648-20-000015EDGAR—
2019-03-182018-12-310001583648-19-000011EDGAR—
2018-03-152017-12-310001583648-18-000017EDGAR—
2017-03-302016-12-310001193125-17-102052EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-122025-09-300001193125-25-276119EDGAR24K words
2025-08-142025-06-300000950170-25-108438EDGAR—
2025-05-152025-03-310000950170-25-071998EDGAR—
2024-11-132024-09-300001437749-24-034891EDGAR—
2024-08-142024-06-300001437749-24-026778EDGAR—
2024-05-152024-03-310001437749-24-017037EDGAR—
2023-11-142023-09-300001437749-23-031957EDGAR—
2023-08-102023-06-300001437749-23-023085EDGAR—
2023-05-112023-03-310001437749-23-013687EDGAR—
2022-11-042022-09-300001437749-22-026023EDGAR—
2022-08-042022-06-300001583648-22-000065EDGAR—
2022-05-112022-03-310001583648-22-000025EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-310001193125-26-133332EDGAR3K words
2026-02-260001104659-26-020667EDGAR—
2026-02-240001104659-26-019143EDGAR—
2026-02-240001193125-26-065308EDGAR—
2026-02-240001193125-26-065159EDGAR—
2026-01-290001193125-26-029341EDGAR—
2026-01-120001193125-26-009724EDGAR—
2025-12-150001104659-25-120789EDGAR—
2025-11-100001193125-25-274378EDGAR—
2025-11-050001104659-25-106591EDGAR—

305 total filings indexed. 273 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001583648
TickerPVLA
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedNV

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 58e96ca5c72be98991af431a0bfa396bdd6de7854f01e57305b22f533a73a4db
parent: 7364ae5e67fc7fa19d3c26e2767e0a48d08d84aec93083402e94af46ec105d3d
content hash: b14dcab19295b436d92674a386bba6cc2cbd7b6f3ef577d185481b8ec523c52a
signed: 2026-04-13T04:47:03.639Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf